$4.33
0.338.25%
Last update: Nov 10, 4:01 PM
AN2 Therapeutics Inc
ANTXNASDAQ
AN2 Therapeutics rose 233.3% from $1.20 to $4.00, ahead of the S&P 500's +9.8%. Its worst day was Oct 13 (−16.3%), and its low came Feb 18 at $1.03.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.31 missed the $-0.22 estimate on $0.00 revenue.
−4.2% · S&P 500 −1.7%
AN2 Therapeutics closed at its lowest level of the year, 14.2% below where the year started.
Story events cover the past 12 months · Times ET
−1.9% · S&P 500 +0.5%
AN2 Therapeutics shares rose 84.2%, while the S&P 500 rose 0.9%.
+84.2%, the year's best day, on 58M shares, the year's heaviest volume · S&P 500 +0.9%
EPS of $-0.29 missed the $-0.24 estimate on $0.00 revenue.
−7.6% · S&P 500 −1.4%
EPS of $-0.29 missed the $-0.23 estimate on $0.00 revenue.
−9.5% · S&P 500 −0.2%
EPS of $-0.18 beat the $-0.24 estimate on $0.00 revenue.
+7.0% · S&P 500 +0.3%
EPS of $-0.17 beat the $-0.20 estimate on $0.00 revenue.
0.0% · S&P 500 +2.4%
Where it ended: a close of $4.00 on Nov 9, 2026.
Nothing in the past 12 months.
All ANTX dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ANTX and SPY from Benzinga historical bars. Not investment advice.
